Remove Access Remove Book Remove Data
article thumbnail

What Could Rescheduling Mean for Medical Cannabis Patients?

Canna Care Docs

Rescheduling would ease those research barriers, improving access to data and education around the plant and opening the door to fully explore the medical benefits cannabis could provide. Ready to book a consultation with one of our experts? Have a question as you embark on your medical cannabis wellness journey?

Patients 111
article thumbnail

Canada: J&J’s Janssen Denied Data Protection Rights For Ketamine Analog Spravato In Canada, Court Rules ‘Not An Innovative Drug’

Cannabis Law Report

The Federal Court of Appeals in Canada ratified a Ministry of Health decision to refuse to provide J anssen Pharmaceuticals, a subsidiary of Johnson and Johnson (NYSE: JNJ ), data protection for Spravato, a ketamine analog approved for depression. What Is Data Protection And Why Is It Important? and Canada. What Happened?

Data 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Marijuana Legalization May Decrease Crime in Nearby States

CannaMD

A recent peer-reviewed article published in the Journal of Drug Issues sought to provide quantitative data on the spillover effect , a term used to describe the influence of legalized marijuana on neighboring states. This data suggests a buffering effect of legalization on crime in neighboring areas, rather than a crime-inducing effect.

article thumbnail

Radicle Science and Open Book Extracts Announce New Alliance to Advance Consumer Trust and CBD Industry Validation

Cannabis Law Report

By uniting the strength of Open Book Extract’s quality innovation and custom product development with Radicle Science’s unbiased scientific rigor in natural products research, we can impact every stage of the product life cycle from ideation to validation. Step five: The OBX and Radicle Science validated product is sent to production.

article thumbnail

Agrify Announces Record Bookings of Over $250 Million in Fourth Quarter 2021

Cannabis Law Report

Q4 2021 Bookings $150 Million Greater Than Prior Guidance of $100 Million. The more than $250 million in new bookings for the fourth quarter of 2021 is $150 million greater than the previously provided fourth quarter guidance of $100 million and over $220 million greater than the bookings the Company generated in the third quarter of 2021.

article thumbnail

Marijuana Legalization Linked to Decline in Youth Drug Treatment Admissions

CannaMD

Over the past two decades, legal access to marijuana across the United States has been steadily increasing. What began as medical access in certain states has quickly expanded to become medical access in most states and recreational legalization in many. MARIJUANA LEGALIZATION & YOUTH DRUG TREATMENT ADMISSIONS.

Treatment 105
article thumbnail

These Patient Advocacy Groups Are Working Together to Expand the Scope of Cannabis Research

Veriheal

RoC also works to increase patients’ access to medical cannabis by helping U.S. Of course, legalization and education efforts can only go so far without data, and that’s where RoC’s research initiatives come into play. To date, Veriheal’s global team has helped hundreds of thousands of patients gain access to medical cannabis.